the majority of children vaccinated before who contracted the disease responded to the infection by an earlier and more intensive production of antibodies than nonvaccinated children who contracted the disease , this pointing to the possibility of manifestation in them of the clinically expressed booster-effect .
C0009450
infection
C0012634
disease